Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Collegium Pharmaceutical stock | 19.02

Own Collegium Pharmaceutical stock in just a few minutes.

Posted

Fact checked

Collegium Pharmaceutical, Inc is a drug manufacturers—specialty & generic business based in the US. Collegium Pharmaceutical shares (COLL) are listed on the NASDAQ and all prices are listed in US Dollars. Collegium Pharmaceutical employs 255 staff and has a trailing 12-month revenue of around USD$301.7 million.

How to buy shares in Collegium Pharmaceutical

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Collegium Pharmaceutical. Find the stock by name or ticker symbol: COLL. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Collegium Pharmaceutical reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$19.02, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Collegium Pharmaceutical, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Collegium Pharmaceutical. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

How has coronavirus impacted Collegium Pharmaceutical's share price?

Since the stock market crash in March caused by coronavirus, Collegium Pharmaceutical's share price has had significant negative movement.

Its last market close was USD$19.02, which is 20.52% down on its pre-crash value of USD$23.93 and 46.31% up on the lowest point reached during the March crash when the shares fell as low as USD$13.

If you had bought USD$1,000 worth of Collegium Pharmaceutical shares at the start of February 2020, those shares would have been worth USD$665.67 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$910.87.

Collegium Pharmaceutical share price

Use our graph to track the performance of COLL stocks over time.

Collegium Pharmaceutical shares at a glance

Information last updated 2020-10-20.
Latest market close USD$19.02
52-week range USD$11.19 - USD$25.59
50-day moving average USD$19.8431
200-day moving average USD$19.0906
Wall St. target price USD$28
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$0.001

Buy Collegium Pharmaceutical shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Vanguard
$0
Stocks, Mutual funds, ETFs, Forex
$1
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
0%
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Collegium Pharmaceutical stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Collegium Pharmaceutical price performance over time

Historical closes compared with the close of $19.02 from 2020-11-16

1 week (2020-11-20) 2.59%
1 month (2020-10-29) 5.43%
3 months (2020-08-28) 4.51%
6 months (2020-05-29) -13.74%
1 year (2019-11-29) -12.47%
2 years (2018-11-29) 0.21%
3 years (2017-11-29) 19.92%
5 years (2015-11-27) 0.11%

Is Collegium Pharmaceutical under- or over-valued?

Valuing Collegium Pharmaceutical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Collegium Pharmaceutical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Collegium Pharmaceutical's EBITDA

Collegium Pharmaceutical's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$48.1 million.

The EBITDA is a measure of a Collegium Pharmaceutical's overall financial performance and is widely used to measure a its profitability.

Collegium Pharmaceutical financials

Revenue TTM USD$301.7 million
Operating margin TTM 4.26%
Gross profit TTM USD$103 million
Return on assets TTM 1.7%
Return on equity TTM 0.16%
Profit margin 0.07%
Book value $4.516
Market capitalisation USD$703.6 million

TTM: trailing 12 months

Shorting Collegium Pharmaceutical shares

There are currently 4.4 million Collegium Pharmaceutical shares held short by investors – that's known as Collegium Pharmaceutical's "short interest". This figure is 3.7% up from 4.2 million last month.

There are a few different ways that this level of interest in shorting Collegium Pharmaceutical shares can be evaluated.

Collegium Pharmaceutical's "short interest ratio" (SIR)

Collegium Pharmaceutical's "short interest ratio" (SIR) is the quantity of Collegium Pharmaceutical shares currently shorted divided by the average quantity of Collegium Pharmaceutical shares traded daily (recently around 328162.44377811). Collegium Pharmaceutical's SIR currently stands at 13.34. In other words for every 100,000 Collegium Pharmaceutical shares traded daily on the market, roughly 13340 shares are currently held short.

However Collegium Pharmaceutical's short interest can also be evaluated against the total number of Collegium Pharmaceutical shares, or, against the total number of tradable Collegium Pharmaceutical shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Collegium Pharmaceutical's short interest could be expressed as 0.13% of the outstanding shares (for every 100,000 Collegium Pharmaceutical shares in existence, roughly 130 shares are currently held short) or 0.1477% of the tradable shares (for every 100,000 tradable Collegium Pharmaceutical shares, roughly 148 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Collegium Pharmaceutical.

Find out more about how you can short Collegium Pharmaceutical stock.

Collegium Pharmaceutical share dividends

We're not expecting Collegium Pharmaceutical to pay a dividend over the next 12 months.

Collegium Pharmaceutical share price volatility

Over the last 12 months, Collegium Pharmaceutical's shares have ranged in value from as little as $11.19 up to $25.59. A popular way to gauge a stock's volatility is its "beta".

COLL.US volatility(beta: 1)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Collegium Pharmaceutical's is 1.0044. This would suggest that Collegium Pharmaceutical's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Collegium Pharmaceutical overview

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes various products for patients suffering from pain. It provides DETERx platform technology that is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods of abuse and misuse, including chewing, crushing, and injecting. The company also offers Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone for opioid medication. In addition, it offers Nucynta ER, an extended release formulation of tapentadol for the management of pain severe enough to require daily, around-the-clock, long term opioid treatment, such as neuropathic pain related to diabetic peripheral neuropathy in adults; and Nucynta IR, an immediate release formulation of tapentadol that is indicated for the management of moderate to severe acute pain in adults. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site